AdvertisementAdvertise with NZME.
Policymakers may struggle to prepare the public for next pandemic.
Parents Mark and Lisa Gallagher lost their daughter Letitia to meningococcal C in 2012. Video / Ministry of Health
OPINION: Mark Dye explains why dried cannabis flowers will a hot topic in the near future.
They've been described as "gamechangers" in the fight against Covid-19.
It also questions commitments to equity; just four of its nearly 150 staff are Māori.
The company will consider a dividend policy once it meets a net debt target.
OPINION: Christine Perrins puts the case for Pharmac to fund a life-changing treatment.
OPINION: Nations paying between 4 and 24 times more than the cost of producing vaccines.
Opinion: Saying some people are going to die is a failure of both empathy and imagination.
Pharma company is closing sites in South Auckland that have operated since the 1990s.
Agency's future is under scrutiny as it juggles public demands and rising drug prices.
Justin Haigh is paying hundreds of thousands for unfunded, potentially life-saving drugs.
The release comes after public pressure for the agency to be more transparent.
Drug company to fund miracle drug for those with CF who have exhausted all options.
Diabetes is the country's biggest and fastest-growing health condition.
Listener: America's opioid epidemic has killed half a million people.
Pharmac now has more than $1 billion to spend every year, but it's nowhere near enough.
Funding for drugs to help young cancer patients tipped to cease over "inconsistency".
Two-year-old Elenna suffers from a rare growth hormone disorder, so rare that there is no official name for it, which means no funding for drugs that can treat the condition. Video / Mark Mitchell
'I had to bury two children and that's something that I don't think I will ever get over.'
A review of the government's drug buyer Pharmac will focus on the timeliness and transparency of its decisions.
Opinion: To provide a safety blanket, we need near-total coverage, with few exceptions.
EDITORIAL: Rollout to frontline workers and household contacts expected in first quarter.